To further evaluate the cancer-cell-killing activity of IFNβ relative to the STINGa ADC, we treated SKBR3 cancer cells in monocultures or in PBMC co-cultures with HER2-ADC or increasing concentrations of IFNβ. This evidence concerns the gene IFNB1 and cancer.